Unknown

Dataset Information

0

Frontotemporal dementia is the leading cause of "true" A-/T+ profiles defined with A?42/40 ratio.


ABSTRACT: Introduction:Patients with positive tauopathy but negative A?42 (A-T+) in the cerebrospinal fluid (CSF) represent a diagnostic challenge. The A?42/40 ratio supersedes A?42 and reintegrates "false" A-T+ patients into the Alzheimer's disease spectrum. However, the biomarker and clinical characteristics of "true" and "false" A-T+ patients remain elusive. Methods:Among the 509 T+N+ patients extracted from the databases of three memory clinics, we analyzed T+N+ patients with normal A?42 and compared "false" A-T+ with abnormal A?42/40 ratio and "true" A-T+ patients with normal A?42/40 ratio, before CSF analysis and at follow-up. Results:24.9% of T+N+ patients had normal A?42 levels. Among them, 42.7% were "true" A-T+. "True" A-T+ had lower CSF tauP181 than "false" A-T+ patients. 48.0% of "true" A-T+ patients were diagnosed with frontotemporal lobar degeneration before CSF analysis and 64.0% at follow-up, as compared with 6% in the "false" A-T+ group (P < .0001). Discussion:Frontotemporal lobar degeneration is probably the main cause of "true" A-T+ profiles.

SUBMITTER: Pouclet-Courtemanche H 

PROVIDER: S-EPMC6378630 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Frontotemporal dementia is the leading cause of "true" A-/T+ profiles defined with Aβ<sub>42/40</sub> ratio.

Pouclet-Courtemanche Hélène H   Nguyen Tri-Bao TB   Skrobala Emilie E   Boutoleau-Bretonnière Claire C   Pasquier Florence F   Bouaziz-Amar Elodie E   Bigot-Corbel Edith E   Schraen Susanna S   Dumurgier Julien J   Paquet Claire C   Lebouvier Thibaud T  

Alzheimer's & dementia (Amsterdam, Netherlands) 20190215


<h4>Introduction</h4>Patients with positive tauopathy but negative Aβ<sub>42</sub> (A-T+) in the cerebrospinal fluid (CSF) represent a diagnostic challenge. The Aβ<sub>42/40</sub> ratio supersedes Aβ<sub>42</sub> and reintegrates "false" A-T+ patients into the Alzheimer's disease spectrum. However, the biomarker and clinical characteristics of "true" and "false" A-T+ patients remain elusive.<h4>Methods</h4>Among the 509 T+N+ patients extracted from the databases of three memory clinics, we analy  ...[more]

Similar Datasets

| S-EPMC3381843 | biostudies-literature
| S-EPMC4312919 | biostudies-literature
| S-EPMC5023509 | biostudies-literature
| S-EPMC2773935 | biostudies-literature
| S-EPMC5562953 | biostudies-literature
| S-EPMC7293665 | biostudies-literature
| S-EPMC9697059 | biostudies-literature
| S-EPMC3576537 | biostudies-literature
| S-EPMC8119343 | biostudies-literature
| S-EPMC6963225 | biostudies-literature